Private Equity

The Health-Care M&A Meter: Hot 2018 to Be Followed by Hotter 2019– The outlook for health-care mergers and acquisitions in 2019 suggests even more transactions this year as compared to 2018, with activity in the hospital and health system sector expected to continue, as well as increasing volume of deals in the physician services, home health. and health-care IT sectors.

M&A activity in orthopedics, GI & more increased in Q4 — 6 numbers to know – Physician specialties such as gastroenterology, orthopedics and urology saw an uptick in private equity consolidation activity in the fourth quarter of 2018, according to Provident Healthcare Partners.

Private equity investments in orthopedics expected to surge in 2019 — Avoid these risks – Robert Aprill shares some insight as to why we should expect to see more private equity recapitalization transactions in orthopedics in 2019.

Health-Care Info Tech Companies Make Moves in November– Health-care information technology companies stole the deal spotlight in November, setting up end-of-year numbers rivaling those of the long-term care, physician practice, and health and hospital system sectors.

The outlook is bright for orthopedic investments, analyst says: 4 things to know – The orthopedic space is a treasure trove of opportunity for private equity investors, according to Provident Healthcare Partners Analyst Robert Aprill.

What GI practices should look for in a PE partner — 5 Qs with Provident’s Abe M’Bodj – Abe M’Bodj shared insights into the gastroenterology private equity market with Becker’s ASC Review.

Q4-2018 Private Equity Industry Update– 2018 resulted in a strong year for private equity fund raising- the second highest fundraising year of all time. The strong deployment of capital has driven up valuation levels and created an even more attractive market for sellers. Despite volatile public market conditions, the outlook for valuations are expected to remain high in 2019.

Evaluating Transaction Considerations – AJ Shekar and Steven Grassa will be hosting a webinar “Evaluating Transaction Considerations” for the Association of Dermatology Administrators and Managers (ADAM).  The webinar will take place Thursday, January 31, 2019, Noon to 1:00 p.m. (ET).  

16th Annual Healthcare and Life Sciences Private Equity and Finance Conference – Kevin Palamara is attending the conference taking place February 20-21 in Chicago. He will also be participating in the panel discussion “Key Opportunities and Issues in Ophthalmology Investments.”

2019 Health Care Services Private Equity Symposium – Scott Davis will be attending the symposium taking place March 6-7 in Miami.

17th Annual Investment and M&A Opportunities in HEALTHCARE: Investing in the Middle-Market Healthcare Sector – Justin Hand is attending the conference taking place March 18-19 in Marina del Ray.

37th Annual J.P. Morgan Healthcare Conference – Justin Hand, Michael Patton, Steven Aguiar, and Scott Davis attended the conference January 7-10 in San Francisco, CA

Private Equity Investment in Physician Services – On January 16, 2019 Provident co-hosted a webinar with Epstein Becker and Green, which focused on private equity investment in physician services. The recording for this webinar is now available.

Big Health System Deals Dominate Transactions in October-The announced merger of two major Texas health systems is October’s deal-of-the-month.

What to Expect in a Due Diligence Process – Episode 7 of Provident’s Healthcare Dealcast

INSIGHT: Long-Term Care Consolidations Lead Third Quarter Health Transactions – The breakneck pace of healthcare transactions continued unabated in the third quarter.

Q3-2018 Private Equity Industry Update– While some of the key metrics for the private equity industry are slightly down from the prior quarter, the industry as a whole is performing at peak level with little indication of any meaningful drop off to come.   

What are some of the factors driving consolidation within physician services?– Episode 5 of Provident’s Healthcare Dealcast

Private Equity Investment in Health Care Stays Strong – Private equity investment is burgeoning throughout the U.S., and health care is one of the “in” targets for investors.

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”